Lipocine Inc (NASDAQ: LPCN) stock closed at $5.54 on 7/18/24 after a major decline of -13.2%. Moreover, this decline was accompanied by unusually high trading volume at 158% of normal. The stock has declined -26.6% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
LPCN’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Lipocine has a current Value Trend Rating of B (Positive). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Lipocine has a poor Appreciation Score of 29 but a very high Power Rating of 96, triggering the Positive Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment